NeuroOne Medical Technologies's ticker is NMTC and the CUSIP is 64130M100. A total of 1 filers reported holding NeuroOne Medical Technologies in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,380,120 | +109.1% | 1,550,000 | +181.8% | 0.20% | +126.7% |
| Q2 2023 | $660,000 | -25.5% | 550,000 | 0.0% | 0.09% | -25.0% |
| Q1 2023 | $885,499 | +34.2% | 550,000 | 0.0% | 0.12% | +26.3% |
| Q4 2022 | $660,000 | -71.4% | 550,000 | -59.7% | 0.10% | -72.9% |
| Q3 2022 | $2,304,000 | +105.9% | 1,363,331 | 0.0% | 0.35% | +98.9% |
| Q2 2022 | $1,119,000 | -28.1% | 1,363,331 | -3.6% | 0.18% | -12.0% |
| Q1 2022 | $1,556,000 | -43.3% | 1,414,172 | 0.0% | 0.20% | -27.3% |
| Q4 2021 | $2,743,000 | -30.6% | 1,414,172 | +41.4% | 0.28% | -29.1% |
| Q3 2021 | $3,950,000 | -40.4% | 1,000,001 | 0.0% | 0.39% | -40.7% |
| Q2 2021 | $6,630,000 | – | 1,000,001 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWM Investment Company, Inc. | 550,000 | $660,000 | 0.10% |